Press Release Archives - Page 2 of 13

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

May 13, 2024

BELGRADE, Mont. , May 13, 2024 -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds

April 30, 2024

BELGRADE, Mont. , April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of two amniotic membrane allografts,

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

April 1, 2024

Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont. , April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

March 21, 2024

BELGRADE, Mont. , March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

March 7, 2024

BELGRADE, Mont. , March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company’s revolving credit agreement with MidCap Financial Trust

Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference

February 26, 2024

BELGRADE, Mont. , Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , Chief Executive Officer, will present at the TD Cowen

Xtant Medical to Participate in Upcoming Investor Conferences

November 9, 2023

BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

November 9, 2023

Raises 2023 Annual Revenue Guidance to $88 Million - $91 Million BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

November 2, 2023

BELGRADE, Mont. , Nov. 02, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended

Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical

October 23, 2023

Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont. , Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced

Xtant Medical Highlights Growing Product Portfolio at NASS 2023

October 12, 2023

BELGRADE, Mont. , Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products

Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business

August 10, 2023

BELGRADE, Mont. , Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it completed the acquisition of certain assets and liabilities